Clincosm LogoSign in Get a demo

Hematological Malignancies

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Hematological Malignancies Trial in Durham (fostamatinib)

Active, not recruiting
  • Hematological Malignancies
  • Durham, North Carolina
    Duke University of Medicine
Jul 14, 2022

Hematological Malignancies Trial in United States (KPG-818)

Recruiting
  • Hematological Malignancies
  • Sacramento, California
  • +9 more
Jul 4, 2022

Hematological Malignancies Trial in Boston, Durham (Pasireotide)

Completed
Has Results
  • Hematological Malignancies
  • Boston, Massachusetts
  • +1 more
Oct 19, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)

Completed
Has Results
  • Hematological Malignancies
  • +3 more
  • Los Angeles, California
  • +14 more
Oct 1, 2020

Hematological Malignancies Trial in Durham (Naive T Cell Depleted Donor Lymphocyte Infusion)

Completed
  • Hematological Malignancies
  • Naive T Cell Depleted Donor Lymphocyte Infusion
  • Durham, North Carolina
    Duke University Medical Center
Feb 12, 2018